rxstat › Drug prices › Varicella-zoster Virus Glycoprotein E Antigen
Varicella-zoster Virus Glycoprotein E Antigen (Shingrix) price in Canada
No current shortage
Varicella-zoster Virus Glycoprotein E Antigen 50 mcg/0.5ml suspension costs about $176.96 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.
Varicella-zoster Virus Glycoprotein E Antigen has no current shortage reported in Canada. It has been in shortage before; the history is below.
Price by province
| Strength and form | AB |
|---|---|
| 50 mcg/0.5ml Suspension | $176.96/unitnot covered |
| Plan coverage | Not covered |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 1 product
- Shingrix 50 mcg/0.5ml Suspension · GSK
Shortage status
Shortage history
Reports by product
What's happening
There are no active shortage reports for Varicella-zoster Virus Glycoprotein E Antigen. Health Canada has 7 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Recent changes
- No changes recorded yet.
Common questions
How much does Varicella-zoster Virus Glycoprotein E Antigen cost in Canada?
Varicella-zoster Virus Glycoprotein E Antigen 50 mcg/0.5ml suspension costs about $176.96 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.
Is Varicella-zoster Virus Glycoprotein E Antigen covered by provincial drug plans?
On the public plans' own lists: Alberta: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
When will Varicella-zoster Virus Glycoprotein E Antigen be back in stock in Canada?
Varicella-zoster Virus Glycoprotein E Antigen has no active shortage; supply is normal per Health Canada reports.
Why is Varicella-zoster Virus Glycoprotein E Antigen in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.